Meridian Bioscience: Fiscal Q2 Earnings Snapshot

May 6, 2022 GMT

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Friday reported earnings of $28.6 million in its fiscal second quarter.

On a per-share basis, the Cincinnati-based company said it had net income of 65 cents. Earnings, adjusted for non-recurring costs, were 66 cents per share.

The diagnostic test maker posted revenue of $111.2 million in the period.

Meridian Bioscience expects full-year earnings in the range of $1.30 to $1.40 per share, with revenue in the range of $330 million to $345 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VIVO at